Skip to main content
Top
Published in: Cancer Cell International 1/2019

Open Access 01-12-2019 | Laryngeal Cancer | Primary research

Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma

Authors: Jia-Jie Tan, Lu Wang, Ting-Ting Mo, Jie Wang, Mei-Gui Wang, Xiang-Ping Li

Published in: Cancer Cell International | Issue 1/2019

Login to get access

Abstract

Background

Laryngopharyngeal reflux (LPR), with its increasing morbidity, is attracting considerable attention. In recent years, the causal role between LPR and laryngeal carcinoma has been debated. The main harmful component of LPR is pepsin, which has been shown to induce mucosal inflammation by damaging the mucous membrane. Thus, pepsin is linked to an increased risk of laryngeal carcinoma, although the potential mechanism remains largely unknown.

Methods

The human laryngeal carcinoma cell lines Hep-2 and Tu212 were exposed to different pepsin concentrations and the morphology, proliferation, migration, secretion of inflammatory cytokines, and epithelial–mesenchymal transition (EMT) of the cells were assessed. To evaluate whether interleukin-8 (IL-8) had a causal relationship with pepsin and EMT, an IL-8 inhibitor was used to suppress IL-8 secretion during pepsin exposure and the expression of EMT markers, cell proliferation, and migration were analyzed.

Results

Pepsin promoted proliferation, colony formation, migration, and IL-8 secretion of Hep-2 and Tu212 cells in vitro. Furthermore, increased pepsin concentrations changed the morphology of Hep-2 and Tu212 cells; levels of the epithelial marker E-cadherin were reduced and those of mesenchymal markers vimentin and β-catenin and the transcription factors snail and slug were elevated. A similar effect was observed in laryngeal carcinoma tissues using immunohistochemistry. IL-8 level was reduced and EMT was restored when pepsin was inhibited by pepstatin. EMT was weakened after exposure to the IL-8 inhibitor, with significant reduction in pepsin-induced cell proliferation and migration.

Conclusions

Pepsin may induce EMT in laryngeal carcinoma through the IL-8 signaling pathway, which indicates that it has potential role in enhancing cell proliferation and metastasis of laryngeal carcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and Pepsin in the development of laryngeal injury. Laryngoscope. 1991;101:1–78.CrossRef Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and Pepsin in the development of laryngeal injury. Laryngoscope. 1991;101:1–78.CrossRef
2.
go back to reference Hawkshaw MJ, Pebdani P, Sataloff RT. Reflux laryngitis: an update, 2009–2012. J Voice. 2013;27:486–94.CrossRef Hawkshaw MJ, Pebdani P, Sataloff RT. Reflux laryngitis: an update, 2009–2012. J Voice. 2013;27:486–94.CrossRef
3.
go back to reference Beltsis A, Katsinelos P, Kountouras J, Kamarianis N, Zavos C, Pournaras A, et al. Double probe pH-monitoring findings in patients with benign lesions of the true vocal folds: comparison with typical GERD and the effect of smoking. Eur Arch Otorhinolaryngol. 2011;268:1169–74.CrossRef Beltsis A, Katsinelos P, Kountouras J, Kamarianis N, Zavos C, Pournaras A, et al. Double probe pH-monitoring findings in patients with benign lesions of the true vocal folds: comparison with typical GERD and the effect of smoking. Eur Arch Otorhinolaryngol. 2011;268:1169–74.CrossRef
4.
go back to reference Chu EA, Kim YJ. Cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41:673–95.CrossRef Chu EA, Kim YJ. Cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41:673–95.CrossRef
5.
go back to reference Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T, et al. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol. 2006;164:367–75.CrossRef Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T, et al. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol. 2006;164:367–75.CrossRef
6.
go back to reference Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol. 2007;165:814–20.CrossRef Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol. 2007;165:814–20.CrossRef
7.
go back to reference Sereg-Bahar M, Jerin A, Hocevar-Boltezar I. Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer. Radiol Oncol. 2015;49:59–64.CrossRef Sereg-Bahar M, Jerin A, Hocevar-Boltezar I. Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer. Radiol Oncol. 2015;49:59–64.CrossRef
8.
go back to reference Langevin SM, Michaud DS, Marsit CJ, Nelson HH, Birnbaum AE, Eliot M, et al. Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22:1061–8.CrossRef Langevin SM, Michaud DS, Marsit CJ, Nelson HH, Birnbaum AE, Eliot M, et al. Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22:1061–8.CrossRef
9.
go back to reference Qadeer MA, Lopez R, Wood BG, Esclamado R, Strome M, Vaezi MF. Does acid suppressive therapy reduce the risk of laryngeal cancer recurrence? Laryngoscope. 2005;115:1877–81.CrossRef Qadeer MA, Lopez R, Wood BG, Esclamado R, Strome M, Vaezi MF. Does acid suppressive therapy reduce the risk of laryngeal cancer recurrence? Laryngoscope. 2005;115:1877–81.CrossRef
10.
go back to reference Ozlugedik S, Yorulmaz I, Gokcan K. Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma? Eur Arch Otorhinolaryngol. 2006;263:339–43.CrossRef Ozlugedik S, Yorulmaz I, Gokcan K. Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma? Eur Arch Otorhinolaryngol. 2006;263:339–43.CrossRef
11.
go back to reference Coca-Pelaz A, Rodrigo JP, Takes RP, Silver CE, Paccagnella D, Rinaldo A, et al. Relationship between reflux and laryngeal cancer. Head Neck. 2013;35:1814–8.CrossRef Coca-Pelaz A, Rodrigo JP, Takes RP, Silver CE, Paccagnella D, Rinaldo A, et al. Relationship between reflux and laryngeal cancer. Head Neck. 2013;35:1814–8.CrossRef
12.
go back to reference Koufman JA, Aviv JE, Casiano RR, Saw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;127:32–5.CrossRef Koufman JA, Aviv JE, Casiano RR, Saw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;127:32–5.CrossRef
13.
go back to reference Abou-Ismail A, Vaezi MF. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Curr Gastroenterol Rep. 2011;13:213–8.CrossRef Abou-Ismail A, Vaezi MF. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Curr Gastroenterol Rep. 2011;13:213–8.CrossRef
14.
go back to reference Li X, Huang Z, Wu T, Wang L, Wu J. Role of laryngopharyngeal reflux on the pathogenesis of vocal cord leukoplakia and early glottic cancer. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49:362–7.PubMed Li X, Huang Z, Wu T, Wang L, Wu J. Role of laryngopharyngeal reflux on the pathogenesis of vocal cord leukoplakia and early glottic cancer. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49:362–7.PubMed
15.
go back to reference Farhath S, He Z, Nakhla T, Saslow J, Soundar S, Camacho J, et al. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics. 2008;121:e253–9.CrossRef Farhath S, He Z, Nakhla T, Saslow J, Soundar S, Camacho J, et al. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics. 2008;121:e253–9.CrossRef
16.
go back to reference Stovold R, Forrest IA, Corris PA, Murphy DM, Smith JA, Decalmer S, et al. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med. 2007;175:1298–303.CrossRef Stovold R, Forrest IA, Corris PA, Murphy DM, Smith JA, Decalmer S, et al. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med. 2007;175:1298–303.CrossRef
17.
go back to reference Crapko M, Kerschner JE, Syring M, Johnston N. Role of extra-esophageal reflux in chronic otitis media with effusion. Laryngoscope. 2007;117:1419–23.CrossRef Crapko M, Kerschner JE, Syring M, Johnston N. Role of extra-esophageal reflux in chronic otitis media with effusion. Laryngoscope. 2007;117:1419–23.CrossRef
18.
go back to reference Knight J, Lively MO, Johnston N, Dettmar PW, Koufman JA. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope. 2005;115:1473–8.CrossRef Knight J, Lively MO, Johnston N, Dettmar PW, Koufman JA. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope. 2005;115:1473–8.CrossRef
19.
go back to reference Samuels TL, Johnston N. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngol. 2010;119:203–8.CrossRef Samuels TL, Johnston N. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngol. 2010;119:203–8.CrossRef
20.
go back to reference Wang L, Liu X, Liu YL, Zeng FF, Wu T, Yang CL, et al. Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs. Otolaryngol Head Neck Surg. 2010;143:765–71.CrossRef Wang L, Liu X, Liu YL, Zeng FF, Wu T, Yang CL, et al. Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs. Otolaryngol Head Neck Surg. 2010;143:765–71.CrossRef
21.
go back to reference Johnston N, Yan JC, Hoekzema CR, Samuels TL, Stoner GD, Blumin JH, et al. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells. Laryngoscope. 2012;122:1317.CrossRef Johnston N, Yan JC, Hoekzema CR, Samuels TL, Stoner GD, Blumin JH, et al. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells. Laryngoscope. 2012;122:1317.CrossRef
22.
go back to reference Kelly EA, Samuels TL, Johnston N. Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line. Otolaryngol Head Neck Surg. 2014;150:618–24.CrossRef Kelly EA, Samuels TL, Johnston N. Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line. Otolaryngol Head Neck Surg. 2014;150:618–24.CrossRef
23.
go back to reference Lorenz KJ, Kraft K, Graf F, Pröpper C, Steinestel K. Role of reflux-induced epithelial–mesenchymal transition in periprosthetic leakage after prosthetic voice rehabilitation. Head Neck. 2014;37:530–6.CrossRef Lorenz KJ, Kraft K, Graf F, Pröpper C, Steinestel K. Role of reflux-induced epithelial–mesenchymal transition in periprosthetic leakage after prosthetic voice rehabilitation. Head Neck. 2014;37:530–6.CrossRef
24.
go back to reference Shellman Z, Aldhahrani A, Verdon B, Mather M, Paleri V, Wilson J, et al. Bile acids: a potential role in the pathogenesis of pharyngeal malignancy. Clin Otolaryngol. 2017;42:969–73.CrossRef Shellman Z, Aldhahrani A, Verdon B, Mather M, Paleri V, Wilson J, et al. Bile acids: a potential role in the pathogenesis of pharyngeal malignancy. Clin Otolaryngol. 2017;42:969–73.CrossRef
25.
go back to reference Tan JJ, Wang L, Huang ZF, Li YF, Tian WD, Liu X, et al. The expression and significance of pepsin in laryngeal carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;51:593–9.PubMed Tan JJ, Wang L, Huang ZF, Li YF, Tian WD, Liu X, et al. The expression and significance of pepsin in laryngeal carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;51:593–9.PubMed
26.
go back to reference Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009;141:559–63.CrossRef Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009;141:559–63.CrossRef
27.
go back to reference Bulmer DM, Ali MS, Brownlee IA, Dettmar PW, Pearson JP. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010;120:777–82.CrossRef Bulmer DM, Ali MS, Brownlee IA, Dettmar PW, Pearson JP. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010;120:777–82.CrossRef
28.
go back to reference Tsai TL, Chang SY, Ho CY, Kou YR. Role of ATP in the ROS-mediated laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats. J Appl Physiol. 1985;2009(106):1584–92. Tsai TL, Chang SY, Ho CY, Kou YR. Role of ATP in the ROS-mediated laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats. J Appl Physiol. 1985;2009(106):1584–92.
29.
go back to reference Sillem M, Hahn U, Coddington CC, Gordon K, Runnebaum B, Hodgen GD. Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey(Macaca fascicularis) model of endometriosis. Fertil Steril. 1998;66:468–73.CrossRef Sillem M, Hahn U, Coddington CC, Gordon K, Runnebaum B, Hodgen GD. Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey(Macaca fascicularis) model of endometriosis. Fertil Steril. 1998;66:468–73.CrossRef
30.
go back to reference Goda AE, Koyama M, Sowa Y. Molecular mechanisms of the antitumor activity of SB225002: a novel microtubule inhibitor. Biochem Pharmacol. 2013;85:1741–52.CrossRef Goda AE, Koyama M, Sowa Y. Molecular mechanisms of the antitumor activity of SB225002: a novel microtubule inhibitor. Biochem Pharmacol. 2013;85:1741–52.CrossRef
31.
go back to reference Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope. 2004;114:2129–34.CrossRef Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope. 2004;114:2129–34.CrossRef
32.
go back to reference Johnston N, Dettmar PW, Lively MO, et al. Effect of Pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol. 2006;115:47–58.CrossRef Johnston N, Dettmar PW, Lively MO, et al. Effect of Pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol. 2006;115:47–58.CrossRef
33.
go back to reference Johnston N, Wells CW, Blumin JH, Toohill RJ, Merati AL. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116:934–8.CrossRef Johnston N, Wells CW, Blumin JH, Toohill RJ, Merati AL. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116:934–8.CrossRef
34.
go back to reference Johnston N, Wells CW, Samuels TL, Blumin JH. Rationale for targeting pepsin in the treatment of reflux disease. Ann Otol Rhinol Laryngol. 2010;119:547–58.CrossRef Johnston N, Wells CW, Samuels TL, Blumin JH. Rationale for targeting pepsin in the treatment of reflux disease. Ann Otol Rhinol Laryngol. 2010;119:547–58.CrossRef
35.
go back to reference Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.CrossRef Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.CrossRef
36.
go back to reference Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.CrossRef Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.CrossRef
37.
go back to reference Samuels T, Hoekzema C, Gould J, Goldblatt M, Frelich M, Bosler M, et al. Local synthesis of pepsin in Barrett’s esophagus and the role of pepsin in esophageal adenocarcinoma. Ann Otol Rhinol Laryngol. 2015;124:893–902.CrossRef Samuels T, Hoekzema C, Gould J, Goldblatt M, Frelich M, Bosler M, et al. Local synthesis of pepsin in Barrett’s esophagus and the role of pepsin in esophageal adenocarcinoma. Ann Otol Rhinol Laryngol. 2015;124:893–902.CrossRef
38.
go back to reference Adams J, Heintz P, Gross N, Andersen P, Everts E, Wax M, et al. Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch. Arch Otolaryngol Head Neck Surg. 2000;126:405–9.CrossRef Adams J, Heintz P, Gross N, Andersen P, Everts E, Wax M, et al. Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch. Arch Otolaryngol Head Neck Surg. 2000;126:405–9.CrossRef
39.
go back to reference Wood JM, Hussey DJ, Woods CM, Watson DI, Carney AS. Biomarkers and laryngopharyngeal reflux. J Laryngol Otol. 2011;125:1218–24.CrossRef Wood JM, Hussey DJ, Woods CM, Watson DI, Carney AS. Biomarkers and laryngopharyngeal reflux. J Laryngol Otol. 2011;125:1218–24.CrossRef
40.
go back to reference Wood J, Hussey DJ, Woods CM, et al. Does gene expression in laryngeal sub-sites differ between patients with laryngopharyngeal reflux and controls? Clin Otolaryngol. 2018;43:158–63.CrossRef Wood J, Hussey DJ, Woods CM, et al. Does gene expression in laryngeal sub-sites differ between patients with laryngopharyngeal reflux and controls? Clin Otolaryngol. 2018;43:158–63.CrossRef
41.
go back to reference Johnston N, Wells CW, Samuels TL, Blumin JH. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol. 2009;118:677–85.CrossRef Johnston N, Wells CW, Samuels TL, Blumin JH. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol. 2009;118:677–85.CrossRef
42.
go back to reference Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63:11–30.CrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63:11–30.CrossRef
43.
go back to reference Johnston N, Bulmer D, Gill GA, Panetti M, Ross PE, Pearson JP, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol. 2003;112:481–91.CrossRef Johnston N, Bulmer D, Gill GA, Panetti M, Ross PE, Pearson JP, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol. 2003;112:481–91.CrossRef
44.
go back to reference Reichel O, Mayr D, Durst F, Berghaus A. E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2008;265:937–42.CrossRef Reichel O, Mayr D, Durst F, Berghaus A. E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2008;265:937–42.CrossRef
45.
go back to reference Galera-Ruiz H, Ríos-Moreno MJ, González-Cámpora R, Ortega I, Fernández A, García-Escudero A, et al. The cadherin-catenin complex in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2011;269:1183–8.CrossRef Galera-Ruiz H, Ríos-Moreno MJ, González-Cámpora R, Ortega I, Fernández A, García-Escudero A, et al. The cadherin-catenin complex in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2011;269:1183–8.CrossRef
46.
go back to reference Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D, et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J. 2008;27:2603–15.CrossRef Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D, et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J. 2008;27:2603–15.CrossRef
47.
go back to reference Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, et al. E-cadherin loss associated with EMT promotes radio resistance in human tumor cells. Radiother Oncol. 2011;99:392–7.CrossRef Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, et al. E-cadherin loss associated with EMT promotes radio resistance in human tumor cells. Radiother Oncol. 2011;99:392–7.CrossRef
48.
go back to reference Yan B, Zhang W, Jiang LY, Qin WX, Wang X. Reduced E-cadherin expression is a prognostic biomarker of non-small cell lung cancer: a metaanalysis based on 2395 subjects. Int J Clin Exp Med. 2014;7:4352–6.PubMedPubMedCentral Yan B, Zhang W, Jiang LY, Qin WX, Wang X. Reduced E-cadherin expression is a prognostic biomarker of non-small cell lung cancer: a metaanalysis based on 2395 subjects. Int J Clin Exp Med. 2014;7:4352–6.PubMedPubMedCentral
49.
go back to reference Pecina Slaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int. 2003;3:17.CrossRef Pecina Slaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int. 2003;3:17.CrossRef
50.
go back to reference Fuxe J, Karlsson MC. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol. 2012;22:455–61.CrossRef Fuxe J, Karlsson MC. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol. 2012;22:455–61.CrossRef
51.
go back to reference Satelli A, Li S. Vimemin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68:3033–46.CrossRef Satelli A, Li S. Vimemin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68:3033–46.CrossRef
52.
go back to reference Cianfrocca R, Tocci P, Spinella F, Di Castro V, Bagnato A, Rosanò L. The endothelin A receptor and epidermal growth factor receptor signaling converge on b-catenin to promote ovarian cancer metastasis. Life Sci. 2012;91:13–4.CrossRef Cianfrocca R, Tocci P, Spinella F, Di Castro V, Bagnato A, Rosanò L. The endothelin A receptor and epidermal growth factor receptor signaling converge on b-catenin to promote ovarian cancer metastasis. Life Sci. 2012;91:13–4.CrossRef
53.
go back to reference Mikami Y, Yamauchi Y, Horie M, Kase M, Jo T, Takizawa H, et al. Tumor necrosis factor superfamily member LIGHT induces epithelial–mesenchymal transition in A549 human alveolar epithelial cells. Biochem Biophys Res Commun. 2012;428:451–7.CrossRef Mikami Y, Yamauchi Y, Horie M, Kase M, Jo T, Takizawa H, et al. Tumor necrosis factor superfamily member LIGHT induces epithelial–mesenchymal transition in A549 human alveolar epithelial cells. Biochem Biophys Res Commun. 2012;428:451–7.CrossRef
54.
go back to reference Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009;28:2940–7.CrossRef Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009;28:2940–7.CrossRef
55.
go back to reference Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J Antibiot (Tokyo). 1970;23:259–62.CrossRef Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J Antibiot (Tokyo). 1970;23:259–62.CrossRef
56.
go back to reference Kim JH, Jang SJ, Yun JW, Jung MH, Woo SH. Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro. PLoS ONE. 2018;13:e0207090.CrossRef Kim JH, Jang SJ, Yun JW, Jung MH, Woo SH. Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro. PLoS ONE. 2018;13:e0207090.CrossRef
57.
go back to reference Chan LP, Liu C, Chiang FY, Wang LF, Lee KW, Chen WT. IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC. Oncotarget. 2017;8:56375–88.PubMedPubMedCentral Chan LP, Liu C, Chiang FY, Wang LF, Lee KW, Chen WT. IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC. Oncotarget. 2017;8:56375–88.PubMedPubMedCentral
58.
go back to reference Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.CrossRef Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.CrossRef
59.
go back to reference Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanismrather than caustic acid injury. Gastroenterology. 2009;137(5):1776–84.CrossRef Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanismrather than caustic acid injury. Gastroenterology. 2009;137(5):1776–84.CrossRef
60.
go back to reference Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.CrossRef Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.CrossRef
Metadata
Title
Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma
Authors
Jia-Jie Tan
Lu Wang
Ting-Ting Mo
Jie Wang
Mei-Gui Wang
Xiang-Ping Li
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2019
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-019-0772-7

Other articles of this Issue 1/2019

Cancer Cell International 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine